Clinical Trials for InventisBio

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: InventisBio

Clinical Trials (7)

NCT07130604
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
PHASE3Not yet recruiting
390 participants
Started: Sep 26, 2025 · Completed: Jul 28, 2027
1 condition1 sponsor0 locations
NCT07035041
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE2Recruiting
120 participants
Started: May 22, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05665699
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
PHASE2Active, not recruiting
80 participants
Started: Apr 17, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor19 locations
NCT05379946
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
92 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06166836
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
PHASE1/PHASE2Recruiting
140 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT06954961
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
640 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT04585035
Study to Evaluate D-1553 in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
180 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2025
3 conditions2 sponsors25 locations